Skip to main content

BARD1 Life Sciences Health Care
Cancer Health Care Healthcare

$1.035 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
11 October 2024 at 3:13am
Register to track BD1 and receive email alerts.

BARD1 Life Sciences Limited engages in the research, development, and commercialization of diagnostic products for the early detection of cancer to enhance patient outcomes in Australia. The company offers hTERT test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for ovarian and breast cancers, and research-stage projects for prostate and other cancers. BARD1 Life Sciences Limited was incorporated in 1983 and is headquartered in Notting Hill, Australia.

Expand Company Description

Market Cap (9-Feb)

$95,239,352 (971st)

Close (9-Dec)

$1.04

Volume (9-Dec)

0

Shortsold (3-Dec)

50,000 (0.05%) (513th)

52w High

$0.000

52w Low

$0.000

P/E

-

EPS

-0.144
Subject
StockBot
BD1 Ann: BARD1 Changes its Name to INOVIQ

StockBot
BD1 Ann: Cleansing Notice - Issued of Four Shares - Resolution 5 AGM

StockBot
BD1 Ann: Application for quotation of securities - BD1

StockBot
BD1 Ann: Application for quotation of securities - BD1

StockBot
BD1 Ann: Results of 2021 Annual General Meeting

StockBot
BD1 Ann: AGM Presentation

StockBot
BD1 Ann: New BARD1 Exosome Liquid Biopsy Project

StockBot
BD1 Ann: Application for quotation of securities - BD1

StockBot
BD1 Ann: Notification regarding unquoted securities - BD1

StockBot
BD1 Ann: US Patent Issued - BARD1 Patent Family Lung Cancer Diagnosis

StockBot
BD1 Ann: EXO-NET ANZSEV Presentation

StockBot
BD1 Ann: BARD1 Presenting at Bell Potter Healthcare Conference

StockBot
BD1 Ann: EXO-NET Presented at Virtual ANZSEV Symposium

StockBot
BD1 Ann: Jobkeeper Payment Notification

StockBot
BD1 Ann: Notice of Annual General Meeting/Proxy Form

StockBot
BD1 Ann: Ceasing to be a substantial holder

StockBot
BD1 Ann: Appendix 4G and Corporate Governance Statement

StockBot
BD1 Ann: Appendix 4C & Quarterly Activities Report

StockBot
BD1 Ann: Change of Director's Interest - Philip Powell

StockBot
BD1 Ann: Amended Remuneration Table Directors Report

StockBot
BD1 Ann: Notice required under listing rule 3.13.1

StockBot
BD1 Ann: Notification of cessation of securities - BD1

StockBot
BD1 Ann: 2021 Annual Report

StockBot
BD1 Ann: BARD1 Appoints New CSO

StockBot
BD1 Ann: Notification of cessation of securities - BD1

StockBot
BD1 Ann: Appendix 4E and Preliminary Financial Report

StockBot
BD1 Ann: Change in substantial holding

StockBot
BD1 Ann: Change of Director's Interest - Powell

StockBot
BD1 Ann: Change of Director's Interest - Dr Geoffrey Cumming

StockBot
BD1 Ann: Change of Director's Interest - Johnston

StockBot
BD1 Ann: Notification of cessation of securities - BD1

StockBot
BD1 Ann: Appendix 2A

StockBot
BD1 Ann: BARD1 Share Purchase Plan Completed Oversubscribed

StockBot
BD1 Ann: Proof-of-Concept for SubB2M ELISA-Based Ovarian Cancer Test

StockBot
BD1 Ann: BARD1 LODGES SPP AND OPTIONS PROSPECTUS

StockBot
BD1 Ann: Appendix 4C & Quarterly Activities Report

StockBot
BD1 Ann: Appendix 2A

StockBot
BD1 Ann: BARD1 Collaborator Uni of QLD Announces Ovarian Cancer Data

StockBot
BD1 Ann: Updated Investor Presentation

StockBot
BD1 Ann: Terms of issue of Options

StockBot
BD1 Ann: Investor Presentation

StockBot
BD1 Ann: Appendix 3B

StockBot
BD1 Ann: BARD1 $15m Placement to Accelerate Cancer Diagnostic Program

StockBot
BD1 Ann: Trading Halt

StockBot
BD1 Ann: BARD1 Investor Presentation

StockBot
BD1 Ann: BARD1 Autoantibody Test Results for Ovarian Cancer Published

StockBot
BD1 Ann: SubB2M Breast Cancer Test Manuscript Submitted

StockBot
BD1 Ann: Update on Legal Proceedings

StockBot
BD1 Ann: R&D Tax Incentive Refund Received

StockBot
BD1 Ann: BARD1 Demonstrates Feasibility of SubB2M-Based IHC Test

Register to track BD1 and receive email alerts.

Similar Companies

Apiam Animal Health
AHX
Capitol Health
CAJ
Healthia
HLA
Healius
HLS
Integral Diagnostics
IDX
Rhythm Biosciences
RHY
Sonic Healthcare ...
SHL
SILK Laser Australia Ltd
SLA
Total Brain
TTB